Catalyst Reaction · NASDAQ: RNTX · Biotechnology
Rein Therapeutics (RNTX): quarterly results, a 27.5% drop and what followed
Rein Therapeutics (RNTX) announced preliminary blinded Phase 2 RENEW data at 7:30 AM ET on Monday, November 16, and the stock went from Friday’s $0.5521 close to as low as $0.2844. It finished the session −27.5% at $0.4000 on 24.3 times its 20-day average volume. Here is how it traded, turn by turn, and how LiveChart’s stack read each one.
By IndicatorStack · · All times ET
The catalyst
What the company released or filed, to the minute it crossed. It’s in the timeline as a shaded row, linked to the source.
How it traded
The price around it, session by session: the gap, the range, the close, with the chart LiveChart draws from those bars.
How the stack read it
LiveChart’s read at each turn: the 5-minute trend (the stack bias), the higher timeframes (Compass), the flow (Undertow) and traps (Tripwire).
How the stack read it, checkpoint by checkpoint
The stack bias is LiveChart’s read of the 5-minute trend at that moment: a green dot is bullish, red bearish, grey no clear direction. Under it, what Compass read on the higher timeframes the trend is measured against.
- BeforeNeutralFri close · $0.553415m and 1h split
- Into the openBearishMon 9:30 AM · $0.499915m and 1h down
- 30 minutes inBearishMon 10:00 AM · $0.365115m and 1h down
- At the closeBearishMon 4:00 PM · $0.402315m and 1h down
- Tuesday’s closeBullishTue 4:00 PM · $0.360415m and 1h still down
- Wednesday’s closeBearishWed 4:00 PM · $0.361915m and 1h split
The timeline
Everything that happened, in order, on one ET clock: the company’s releases and SEC filings next to the price and the stack’s own turns.
- ReleaseSECShaded rows are the catalyst: the company’s own releases and filings
- PriceThe session’s open, high, low and close
- StackLiveChart’s 5-minute bias changed
- TriggerA hypothetical entry at the default settings
- TripwireA break of a level that failed to hold
Monday, November 16
- SECQuarterly report (Form 10-Q) filedAccepted by the SEC at 6:40:46 AM ET
- ReleasePreliminary blinded Phase 2 RENEW dataPress release, GlobeNewsWire
- PricePremarket high $0.6450+16.8% from the prior close
- SECCurrent report (Form 8-K) filedAccepted by the SEC at 8:37:54 AM ET
- Stack5-minute stack bias turned bearishat $0.5029
- PriceOpened at $0.5000−9.4% from Friday’s $0.5521 close
- PriceSession low $0.2844
- TripwireTripwire flagged a trap at the lowsa push through support that failed to hold, at $0.3000
- TripwireTripwire flagged a trap at the highsa push through resistance that failed to hold, at $0.4201
- TriggerTrigger marked a short at $0.4011Hypothetical, default settings: reached $0.3880 at 2:05 PM for +3.3% (volume flow turned up)
- TriggerTrigger marked a short at $0.3771Hypothetical, default settings: closed at $0.3924 at 2:45 PM for −4.1% (stop)
- PriceClosed at $0.4000, −27.5% on the day8.5M shares, 24.3× its 20-day average
Tuesday, November 17
- PriceOpened at $0.3800−5.0% from Monday’s $0.4000 close
- PriceSession low $0.3249
- Stack5-minute stack bias went neutralat $0.3701, its inputs no longer agreeing
- Stack5-minute stack bias turned bullishat $0.3745
- PriceClosed at $0.3564, −10.9% on the day2.5M shares, 3.3× its 20-day average
Wednesday, November 18
- PriceOpened at $0.3660+2.7% from Tuesday’s $0.3564 close
- Stack5-minute stack bias went neutralat $0.3709, its inputs no longer agreeing
- TriggerTrigger marked a short at $0.3630Hypothetical, default settings: reached $0.3566 at 2:50 PM for +1.8% (reclaimed VWAP or the fast EMA)
- Stack5-minute stack bias turned bearishat $0.3656
- PriceSession low $0.3496
- PriceClosed at $0.3553, −0.3% on the day816K shares, 1.0× its 20-day average
Friday, November 13
Before the catalyst
Rein Therapeutics closed Friday at $0.5521. The 5-minute stack bias was neutral, its inputs disagreeing. Compass read “15m and 1h split” (15m ↗ 1h ↘ 2h ↘ 4h ↘ D ↓). Undertow: hidden buying, price lower, flow higher. Tripwire: Longs: Clean, nothing major in the way. Its Next row read “Range 0.5333 to 0.5683, no edge in the middle”.
Over the year before, it had traded between $0.5010 and $2.10. The daily chart below shows where it was trading, and the bar the catalyst printed.
Neutral5m stack bias · $0.5534
- Compass
- 15m and 1h split
- Undertow
- Hidden buying
- Tripwire
- Longs: Clean
- Next
- Range 0.5333 to 0.5683, no edge in the middle
Monday, November 16
The quarterly results and a 27.5% drop
The release crossed at 7:30 AM ET, with the company’s Form 8-K accepted by the SEC at 8:37 AM. It opened at $0.5000, −9.4%, and the regular session ranged from $0.2844 to $0.5000 before closing at $0.4000. It did this on a day SPY fell 1.9% and XBI, the biotechnology ETF, fell 3.1%.
Into the open the stack read it as bearish (firm) with 2 of 2 higher timeframes down, and Undertow read “sellers in control”. Thirty minutes in, the picture had changed: price held above VWAP at $0.3488 and the Next row read “Bounce, resistance to hold at 0.4113 (slow EMA)”. By the close the 5-minute bias was bearish from 9:10 AM, while Compass still read “15m and 1h down”: the day’s trend on the 5-minute chart had turned while the higher timeframes it is measured against had not.
Bearishfirm · 5m stack bias · $0.4999
- Compass
- 15m and 1h down
- Undertow
- Sellers in control
- Tripwire
- Shorts: Clean
- Next
- Trend down, fast EMA at 0.5066, longs run against the bias
Bearishweakening · 5m stack bias · $0.3651
- Compass
- 15m and 1h down
- Undertow
- Volume surge
- Tripwire
- Shorts: Clean
- Next
- Bounce, resistance to hold at 0.4113 (slow EMA)
Bearishweakening · 5m stack bias · $0.4023
- Compass
- 15m and 1h down
- Undertow
- Sellers in control
- Tripwire
- Shorts: Avoid
- Next
- Reclaimed VWAP 0.3924, sellers need a rejection
Tuesday, November 17
The session after
It opened at $0.3800 (−5.0%) and traded from $0.3249 to $0.4050, closing at $0.3564, −10.9% on 2.5M shares, still 3.3 times its 20-day average. The 5-minute stack bias was bullish (weakening), since 3:25 PM: momentum up, net buying and trend strength with the buyers. Compass read “15m and 1h still down” (15m ↘ 1h ↓ 2h ↓ 4h ↘ D ↓). Undertow: buyers in control, real size behind the push. Tripwire: Longs: Clean, nothing major in the way.
Bullishweakening · 5m stack bias · $0.3604
- Compass
- 15m and 1h still down
- Undertow
- Buyers in control
- Tripwire
- Longs: Clean
- Next
- Pullback, support to hold at 0.3574 (slow EMA)
Wednesday, November 18
The session after
It opened at $0.3660 (+2.7%) and traded from $0.3496 to $0.3899, closing at $0.3553, −0.3% on 816K shares, still 1.0 times its 20-day average. The 5-minute stack bias was bearish (weakening), since 1:40 PM: under VWAP 0.3691 and a falling SMA, momentum down. Compass read “15m and 1h split” (15m ↗ 1h ↘ 2h ↘ 4h ↓ D ↘). Undertow: buyers pushing back, flow turning against the bias. Tripwire: Shorts: Avoid, resistance looks thin, buying tape on it.
After hours it last traded at $0.3553, with Undertow reading “buyers pushing back”.
Bearishweakening · 5m stack bias · $0.3619
- Compass
- 15m and 1h split
- Undertow
- Buyers pushing back
- Tripwire
- Shorts: Avoid
- Next
- Bounce, resistance to hold at 0.3691 (VWAP)
Bearishweakening · 5m stack bias · $0.3553
- Compass
- 15m and 1h down
- Undertow
- Buyers pushing back
- Tripwire
- Shorts: Avoid
- Next
- Trend down, fast EMA at 0.3566, longs run against the bias
Shares, float and insiders
The supply picture
What the company has outstanding, and what its insiders and its share history show, from its SEC filings.
- Shares outstanding
- 86.3Mas reported to the SEC
- Float
- 66.1M77% of shares outstanding
- Reverse splits on record
- 11-for-20 reverse split, November 11, 2022
- Last insider purchase
- May 27, 20265K shares at $1.07 by VON RICKENBACH JOSEF H (director)
Releases and filings
Sources
The company’s own releases and its filings with the SEC, newest first, each with the time it crossed.
- SECCurrent report (Form 8-K)Mon Nov 16, 8:37 AM ET · SEC EDGAR
- ReleasePreliminary blinded Phase 2 RENEW dataMon Nov 16, 7:30 AM ET · GlobeNewsWire
- SECQuarterly report (Form 10-Q)Mon Nov 16, 6:40 AM ET · SEC EDGAR
In short
Questions
Why did RNTX stock go down on November 16?
Rein Therapeutics (RNTX) announced preliminary blinded Phase 2 RENEW data at 7:30 AM ET on Monday, November 16, and the stock went from Friday’s $0.5521 close to as low as $0.2844. It finished the session −27.5% at $0.4000 on 24.3 times its 20-day average volume. The reaction describes the sequence and infers no cause.
What did Rein Therapeutics announce on November 16, 2026?
Rein Therapeutics (RNTX) announced preliminary blinded Phase 2 RENEW data at 7:30 AM ET on Monday, November 16.
How did RNTX stock trade on November 16?
RNTX opened at $0.5000, −9.4% from the prior close of $0.5521, traded between $0.2844 and $0.5000 in the regular session and closed at $0.4000, −27.5%, on 8.5M shares.
How did LiveChart’s stack read RNTX at the close on November 16?
At the 4:00 PM ET close the 5-minute stack bias on RNTX was bearish (weakening), Compass read “15m and 1h down” and Undertow read “sellers in control”. Each turn of the read is on this page’s timeline.
What does LiveChart’s stack read on RNTX now?
The read on this page is fixed at each moment it describes. LiveChart reads RNTX on every bar as it trades: open it on LiveChart for the current stack bias, levels and every layer.
Every catalyst on RNTX
RNTX’s catalyst history
This is RNTX’s first Catalyst Reaction. Each time it moves on a release or a filing again, the reads line up here side by side, so how it reacts to its own news builds into a history.
| Session | The catalyst | The day | Next session | Stack bias at the close |
|---|---|---|---|---|
| Nov 16, 2026This reaction | Preliminary blinded Phase 2 RENEW dataEarnings · 7:30 AM ET | −27.5% | −10.9% | Bearish |
Also on Monday, November 16
More Catalyst Reactions from that session
- Nov 169:00 AM ETCYAB+53.7%Cyabra, Inc. Common Stock (CYAB): an offering, a 53.7% session and a $0.0000 offeringOffering363.6× avg volume
- Nov 168:30 AM ETGMM+97.1%Global Mofy Metaverse (GMM): Mofy announces Indirect investment in Anthropic, a 97.1% session and what followedCompany news862.7× avg volume
- Nov 168:30 AM ETMBOT−34.2%Microbot Medical (MBOT): quarterly results, a 34.2% drop and what followedEarnings11.0× avg volume
- Nov 168:30 AM ETUSDE−24.0%StablecoinX (USDE): quarterly results, a 24.0% drop and what followedEarnings0.2× avg volume
- Nov 167:30 AM ETMNTK+22.6%Montauk Renewables (MNTK): quarterly results, a 22.6% session and what followedEarnings10.0× avg volume
- Nov 167:00 AM ETHIHO+52.9%Highway (HIHO): Declares US$0.43228 cash per share special, a 52.9% session and what followedCompany news3,163.5× avg volume
Every Reaction From Nov 16More Earnings ReactionsRNTX Catalyst HistoryRNTX on LiveChartTechnical Setups RadarAll Catalyst ReactionsIntraday Movers
Further reading: Gaps: continuation and exhaustionLow-float riskWhat VWAP tells youTrading around halts
General market information from the company’s releases, its SEC filings, the session’s prices and LiveChart’s reads. Prices are indicative. It describes what happened and when, infers no cause, takes no view on what comes next and is not a recommendation to buy or sell any security. Trigger trades are hypothetical. Read the Risk Disclosure.